Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Stanford University, Stanford, California

University of Miami Miller School of Medicine, Miami, Florida

University of Louisville, Louisville, Kentucky

Texas Heart Institute, Houston, Texas